Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.08) per share which beat the analyst consensus estimate of $(2.71) by 60.15 percent. This is a 82.61 percent increase over losses of $(6.21) per share from the same period last year. The company reported quarterly sales of $89.05 million which beat the analyst consensus estimate of $45.00 million by 97.88 percent. This is a 60.65 percent increase over sales of $55.43 million the same period last year.